Fluid therapy monitoring for kidney injury in cirrhosis
Part of Digestive system, Kidney & urinary clinical trials.
This trial studies a method to help doctors detect and manage kidney injury in people with cirrhosis (liver scarring). It aims to find the best way to treat kidney problems that happen suddenly, which may help improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have cirrhosis (a liver condition where the liver is scarred and doesn't work well).
- You must be in the hospital because of a sudden worsening of your liver condition or for evaluation.
- Your kidneys must not have failed completely, and you must not be on dialysis.
- You must not have had a kidney transplant.
- You cannot be pregnant.
- You must not have an active cancer other than liver cancer.
- You must not have had major bleeding from your stomach or intestines in the last 5 days.
- You must not have taken certain medicines (like pain relievers, some antibiotics, or contrast dyes) in the last 7 days.
- You must not have a blockage in your urinary tract.
- You must not have an active infection.
- You must not have blood disorders like leukemia or aplastic anemia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with liver cirrhosis who develop acute kidney injury while in the hospital, to understand what factors might increase the risk of dying within 30 days. It aims to help doctors better predict and possibly prevent these deaths.
This study tests whether giving albumin through a vein helps people with cirrhosis who have a certain type of kidney problem (called acute kidney injury). The goal is to see if albumin works better than a simple saltwater solution in improving kidney function.
This study tests whether giving a common fluid (albumin) early can help protect the kidneys in people with advanced liver disease who have a sudden kidney injury. It aims to see if this simple treatment can improve recovery and prevent the need for dialysis.
This study looks at how liver cirrhosis affects kidney health. If you have cirrhosis, researchers will check your kidney function and track changes over a short time to learn more about kidney problems in people with cirrhosis.
This trial studies two ways of giving albumin (a protein given through an IV) to people with cirrhosis who also have a sudden kidney injury from sepsis. The goal is to see which method—tailored to each patient or a fixed dose—is safer and works better for kidney recovery.
This study looks at acute kidney injury in patients who are very sick in the intensive care unit (ICU). It may help doctors better understand and manage kidney problems in these patients.
Hear when a new AKI in Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.